About

About 3SBio Inc. Founded in 1993,3SBio Inc. is a high-tech biopharmaceuticals with R&D, production and sale. More than 30 products are currently saled on the market across all provinces in China and more than 20 countries. CDMO business of 3SBio Inc. was launched in 2014, currently comprises Northern Medicine Valley Desen (Shenyang) Biologics Co., Ltd. (“Desen Biologics”), Shanghai SIGO Biologics Ltd. (“SIGO Biologics”), Guangdong Sunshine Pharmaceutical Co., Ltd. (“Guangdong Sunshine”) and Sirton Pharmaceuticals S.p.A. (“Sirton”) in Italy, all being 3SBio’s subsidiaries. The company provides our customers with one-step service for contract development and manufacturing of biologics, gene therapy and cell therapy. The services based on technology platforms expressed by microorganisms and mammalian cells, provide service for various biologics (recombinant proteins, antibodies, etc.),gene therapy (plasmid, mRNA, viral vector, etc.) and cell therapy (immune cell, etc.). Founded in 1993,3SBio Inc. is a high-tech biopharmaceuticals with R&D, production and sale. More than 30 products are currently saled on the market across all provinces in China and more than 20 countries. CDMO business of 3SBio Inc. was launched in 2014, currently comprises Northern Medicine Valley Desen (Shenyang) Biologics Co., Ltd. (“Desen Biologics”), Shanghai SIGO Biologics Ltd. (“SIGO Biologics”), Guangdong Sunshine Pharmaceutical Co., Ltd. (“Guangdong Sunshine”) and Sirton Pharmaceuticals S.p.A. (“Sirton”) in Italy, all being 3SBio’s subsidiaries. The company provides our customers with one-step service for contract development and manufacturing of biologics, gene therapy and cell therapy. The services based on technology platforms expressed by microorganisms and mammalian cells, provide service for various biologics (recombinant proteins, antibodies, etc.),gene therapy (plasmid, mRNA, viral vector, etc.) and cell therapy (immune cell, etc.).